ERK regulation upon contact inhibition in fibroblasts

Molecular and Cellular Biochemistry

Volumn 286, Issue 1-2, 2006, Pages 181-189

  Wayne, Joshua ^a   Sielski, Jennifer ^a   Rizvi, Ahmed ^a   Georges, Ketleine ^a   Hutter, Dorothy ^a  

^a MONMOUTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTERASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 2; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 3; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL DENSITY; CELL GROWTH; CONTACT INHIBITION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INACTIVATION; FIBROBLAST CULTURE; FIBROSARCOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL LINE; CELL LINE, TUMOR; CONTACT INHIBITION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; HUMANS; IMMEDIATE-EARLY PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; OXIDATION-REDUCTION; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 33646229108     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-9089-z     Document Type: Article

References (54)

1. Holley RW: Control of growth of mammalian cells in culture. Nature 258: 487-490, 1975
2. Wieser RJ, Hack R, Oesch F: Involvement of plasma membrane glycoproteinsin the contact-dependent inhibition of growth of human fibroblasts. Exp Cell Res 158: 493-499, 1995
3. Gradl G, Faust D, Oesch F, Wieser RJ: Density-dependent regulation of cell growth by contactinhibin and the contactinhibin receptor. Current Biol 5: 535-536, 1995
4. Robinson MJ, Cobb MH: Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9: 180-186, 1997
5. Pelech SL: Networking with protein kinases. Curr Biol 3: 513-515, 1993
6. Kolch W: Meaningful Telationships: the regulation of the Ras/Raf/ MEK/ ERK pathway by protein interactions. Biochem J 351: 289-305, 2000
7. Pelech SL, Charest DL: MAP kinase-dependent pathways in cell cycle control. Prog Cell Cycle Res.1: 33-52, 1995
8. Ono K, Han J: The p38 signal trAnsduction pathway: activation and function. Cell Signal 12: 1-13, 2000
9. Keyse SM: Protein phosphatases and the regulation of mitogen-activated protein kinase signaling. Curr Opin Cell Biol 12: 186-192, 2000
10. Zhang ZY, Zhou B, Xie L: Modulation of protein kinase signaling by protein phosphatases and inhibitors. Pharm Therapeutics 93: 307-317, 2002
11. Liu Y, Gorospe M, Yang C,Holbrook NJ: Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress: inhibition of c-Jun N-terminal kinase activity and AP-1 dependent gene activation. J Biol Chem 270: 8377-8380, 1995
12. Tanoue T, Nishida E: Molecular recognitions in MAP kinase cascades. Cellular Signalling 15 455-462, 2003
13. Hutter DE, Till BG, Greene JJ: Redox state changes in density-dependent regulation of proliferation. Exp Cell Res 232: 435-438, 1997
14. Monteiro HP, Stern A: Redox modulation of tyrosine phosphorylation-dependent signal transduction pathways. Free Radic Biol Med 21: 323-333, 1996
15. Hutter D, Greene JJ: Influence of the cellular redox state on NF-KB-regulated gene expression. J Cell Physiol 183: 45-52, 2000
16. Pouyssegur J, Volmat V, Lenormand P: Fidelity and spatio-temporal control in MAP kinase (ERKs) signaling. Biochem Pharmacol 64: 755-763, 2002
17. Maestroni A, Tentori F, Meregalli G, Gabellini D, Asnaghi V, Ruggierri D, Zerbini G: Inhibition of MAP kinase cascade normalizes the proliferation of fibroblasts from patients with type 1 diabetes and nephropathy. J Diabetes Complications 19: 291-296, 2005
18. Yoshii M, Jikuhara A, Mori S, Iwagaki H, Takahashi HK, Nishibori M, Tanaka N: Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin-and MAP kinase-dependent manners. J Pharmacol Sci 98: 450-458, 2005
19. Wu Z, Wu LJ, Tashiro S, Onodera S, Ikejima T: Phosphorylated extracellular signal-regulated kinase up-regulated p53 expression on shikonin-induced HeLa cell apoptosis. Chin Med J (Engl) 118: 671-677, 2005
20. Elder DL, Halton DE, Playle LC, Paraskeva C: The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells. Int J Cancer 99: 323-327, 2002
21. Theodosiou A, Ashworth A: MAP kinase phosphatases. Genome Biol 3: 1-10, 2002
22. Schafer FQ, Buettner GR: Redox environment of the cell as viewed through the redox stateof the glutathione disulfide/glutathione couple. Free Rad Biol Med 30: 1191-1212, 2001
23. Griffith OW: Mechanism of action, metabolism, and toxicity of buthionine sulfoximine andits higher homologs, potent inhibitors of glutathione synthesis. J Biol Chem 257: 13704-13712, 1982
24. Roovers K, Assoian RK: Integrating the MAP kinase signal into the G1 cell cycle phase machinery. Bioessays 22: 818-826, 2000
25. Polk DB, McCollum GW, Carpenter G: Cell density-dependent regulation of PLC gamma 1tyrosine phosphorylation and catalytic activity in an intestinal cell line (IEC-6) J Cell Physiol 162: 427-433, 1995
26. Bedrin MS, Abolafia CM, Thompson JF: Cytoskeletal association of epidermal growth factorreceptor and associated signaling proteins is regulated by cell density in IEC-6 intestinal cells. J Cell Physiol 172: 126-136, 1997
27. Vinals F, Pouyssegur J: Confluence of vascular endothelial cells induces cell cycle exitby inhibiting p42/p44 mitogen-activated protein kinase activity. Mol Cell Biol 19: 2763-2772, 1999
28. Li S, Gerrard ER, Balkovetz DF: Evidence for ERK1/2 phosophorylation controlling contact inhibition of proliferation in Madin-Darby Canine Kidney Epithelial cells. Am J Physiol 287: C432-439, 2004
29. Calipel A, Lefevre G, Pouponnot C, Mouriaux F, Eychene A, Mascarelli F: Mutation of B-Raf in human choroidal melanoma cells mediates cell proliferation and transformation through the MEK/ERK pathway. J Biol Chem 278: 42409-42418, 2003
30. Gysin S, Lee SH, Dean NM, McMahon M: Pharmacologic inhibition of RAF, MEK, ERK signalingelicits pancreatic cancer cell arrest through induced expression of p27Kip1. Cancer Res 65: 4870-4880, 2005
31. Sun H, Tonks NK, Bar-Sagi D: Inhibition of Ras-induced DNA synthesis by expression of the phosphatase MKP-1. Science 266: 285-288, 1994
32. Brondello JM, McKenzie FR, Sun H, Tonks NK, Pouyssegur J: Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts. Oncogene 10: 1895-1904, 1995
33. Haddad JJ, Harb HL: L-γ-Glutamyl-L-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory cytokines: A signaling transcriptional scenario for redox(y) immunologic sensor(s)? Mol Immunol 42: 987-1014, 2005
34. Attene-Ramos K, Kitiphongspattana K, Ishii-Schrade K, Gaskins HR: Density-dependent changes in intracellular redox status in IEC-6 cells. 44 th Annual Meeting, The American Society for Cell Biology, 2004
35. Kamata H, Hirata H: Redox regulation of cellular signaling. Cell Signal 11: 1-14, 1999
36. Fischer EH, Charbonneau HA Tonks NK: Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science 253: 401-406, 1991
37. Kabe Y, Ando K, Hirao S, Yoshida M, Handa H: Redox regulation of NF-kappaB activation: Distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 7: 395-403, 2005
38. Mendelson KG, Contois LR, Tevosian SG, Davis RJ, Paulson KE: Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc Natl Acad Sci USA 93: 12908-23913, 1996
39. Fialkow L, Chan CK, Rotin D, Grinstein S, Downey GP: Activation of the mitogen-activatedprotein kinase signaling pathway in neutrophils: Role of oxidants. J Biol Chem 269: 31234-31242, 1994
40. Wang X, Martindale JL, Liu Y, Holbrook NJ: The cellular response to oxidative stress: Influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem J 333: 291-300, 1998
41. 2. Role in cell survival following oxidant injury. J Biol Chem 271: 4138-4142, 1996
42. Marshall CJ: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185, 1995
43. Shepherd EG, Zhao Q, Welty SE, Hansen TN, Smith CV, Liu Y: The function of mitogen-activated protein kinase phosphatase-1 in peptidoglycan-stimulated macrophages. J Biol Chem 279: 54023-54031, 2004
44. Lee YJ, Shukla SD: Pro- and anti-apoptotic roles of c-Jun N-terminal kinase (JNK) in ethanol and acetaldehyde exposed rat hepatocytes. Eur J Pharmacol 508: 31-45, 2005
45. Tong Z, Singh G, Rainbow AJ: Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy. Cancer Res 62: 5528-5535, 2002
46. Steinmetz R, Wagoner HA, Zeng P, Hammond JR, Hannon TS, Meyers JL, Pescovitz OH: Mechanisms regulating the constitutive activation of the extracellular-signal regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1/2 on cancer cell proliferation. Mol Endocrinol 18: 2570-2582, 2004
47. Faust D, Dolado I, Cuadrado A, Oesch F, Weiss C, Nebreda AR, Dietrich C: p38alpha MAPK is required for contact inhibition. Oncogene [Epub ahead of print], 2005
48. Cazillis M, Bringuier AF, Delautier D, Buisiine M, Bernuau D, Gespach C, Groyer A: Disruption of MKK4 signaling reveals its tumor-suppressor role in embryonic stem cells. Oncogene 23: 4735-4744, 2004
49. McGinn S, Saad S, Poronnic P, Pollock C: High glucose mediated effects on endothelial cell proliferation occur via p38 MAP kinase. Am J Physiol Endocrinol Metab 285: E708-717, 2003
50. Lallemand D, Ham J, Garbay S, Bakiri L, Traincard F, Jeannequin O, Pfarr CM, Yaniv M: Stress-activated protein kinases are negatively regulated by cell density. EMBO J 17: 5615-5626, 1998
51. Suzuki E, Nagata D, Yoshizumi M, Kakoki M, Goto A, Omata M, Hirata Y: Reentry into the cell cycle of contact-inhibited vascular endothelial cells by a phosphatase inhibitor. J Biol Chem 275: 3637-3644, 2000
52. Suzuki E, Nishimatsu H, Nagata D, Satonaka H, Goto A, Omata M, Fujita T, Nagai R, and Hirata, Y: Constitutive activation of proto-oncogene protein p21 induces cell cycle arrest in the G1 phase in contact-inhibited vascular endothelial cells. Hypertens Res 25: 773-778, 2002
53. Zhong Y, Lopez-Barcons L, Haigentz M, Ling YH, Perez-Soler R: Exogenous expression of H-cadherin in CHO cells regulates contact inhibition of cell growth by inducing p21 expression. Int J Oncol 24: 1573-1579, 2004
54. Batt DB, Roberts TM: Cell density modulates protein-tyrosine phosphorylation. J Biol Chem 273: 3408-3414, 1998